Drug safety evaluation:
"Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"...Provided by publisher
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Hoboken, New Jersey
Wiley
[2017]
|
Ausgabe: | 3rd edition |
Schlagworte: | |
Zusammenfassung: | "Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"...Provided by publisher |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xxvii, 886 Seiten Diagramme |
ISBN: | 9781119097396 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV044044101 | ||
003 | DE-604 | ||
005 | 20170921 | ||
007 | t | ||
008 | 170215s2017 xxu|||| |||| 00||| eng d | ||
010 | |a 016014287 | ||
020 | |a 9781119097396 |9 978-1-119-09739-6 | ||
035 | |a (OCoLC)968955734 | ||
035 | |a (DE-599)BVBBV044044101 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-29T |a DE-19 | ||
050 | 0 | |a RA1238 | |
082 | 0 | |a 615/.19 |2 23 | |
084 | |a VS 5360 |0 (DE-625)147688:253 |2 rvk | ||
100 | 1 | |a Gad, Shayne C. |d 1948- |0 (DE-588)13238440X |4 aut | |
245 | 1 | 0 | |a Drug safety evaluation |c Shayne Cox Gad |
250 | |a 3rd edition | ||
264 | 1 | |a Hoboken, New Jersey |b Wiley |c [2017] | |
300 | |a xxvii, 886 Seiten |b Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
520 | |a "Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"...Provided by publisher | ||
650 | 4 | |a Drug Evaluation, Preclinical | |
650 | 4 | |a Drug Evaluation | |
650 | 4 | |a Product Surveillance, Postmarketing | |
650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
689 | 0 | |5 DE-604 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-029451084 |
Datensatz im Suchindex
_version_ | 1804177056651542528 |
---|---|
any_adam_object | |
author | Gad, Shayne C. 1948- |
author_GND | (DE-588)13238440X |
author_facet | Gad, Shayne C. 1948- |
author_role | aut |
author_sort | Gad, Shayne C. 1948- |
author_variant | s c g sc scg |
building | Verbundindex |
bvnumber | BV044044101 |
callnumber-first | R - Medicine |
callnumber-label | RA1238 |
callnumber-raw | RA1238 |
callnumber-search | RA1238 |
callnumber-sort | RA 41238 |
callnumber-subject | RA - Public Medicine |
classification_rvk | VS 5360 |
ctrlnum | (OCoLC)968955734 (DE-599)BVBBV044044101 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
edition | 3rd edition |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01465nam a2200421 c 4500</leader><controlfield tag="001">BV044044101</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170921 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170215s2017 xxu|||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">016014287</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781119097396</subfield><subfield code="9">978-1-119-09739-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)968955734</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044044101</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA1238</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5360</subfield><subfield code="0">(DE-625)147688:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gad, Shayne C.</subfield><subfield code="d">1948-</subfield><subfield code="0">(DE-588)13238440X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug safety evaluation</subfield><subfield code="c">Shayne Cox Gad</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3rd edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, New Jersey</subfield><subfield code="b">Wiley</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxvii, 886 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"...Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Product Surveillance, Postmarketing</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029451084</subfield></datafield></record></collection> |
id | DE-604.BV044044101 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:42:01Z |
institution | BVB |
isbn | 9781119097396 |
language | English |
lccn | 016014287 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029451084 |
oclc_num | 968955734 |
open_access_boolean | |
owner | DE-29T DE-19 DE-BY-UBM |
owner_facet | DE-29T DE-19 DE-BY-UBM |
physical | xxvii, 886 Seiten Diagramme |
publishDate | 2017 |
publishDateSearch | 2017 |
publishDateSort | 2017 |
publisher | Wiley |
record_format | marc |
spelling | Gad, Shayne C. 1948- (DE-588)13238440X aut Drug safety evaluation Shayne Cox Gad 3rd edition Hoboken, New Jersey Wiley [2017] xxvii, 886 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index "Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"...Provided by publisher Drug Evaluation, Preclinical Drug Evaluation Product Surveillance, Postmarketing Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 s DE-604 |
spellingShingle | Gad, Shayne C. 1948- Drug safety evaluation Drug Evaluation, Preclinical Drug Evaluation Product Surveillance, Postmarketing Arzneimittelsicherheit (DE-588)4143182-0 gnd |
subject_GND | (DE-588)4143182-0 |
title | Drug safety evaluation |
title_auth | Drug safety evaluation |
title_exact_search | Drug safety evaluation |
title_full | Drug safety evaluation Shayne Cox Gad |
title_fullStr | Drug safety evaluation Shayne Cox Gad |
title_full_unstemmed | Drug safety evaluation Shayne Cox Gad |
title_short | Drug safety evaluation |
title_sort | drug safety evaluation |
topic | Drug Evaluation, Preclinical Drug Evaluation Product Surveillance, Postmarketing Arzneimittelsicherheit (DE-588)4143182-0 gnd |
topic_facet | Drug Evaluation, Preclinical Drug Evaluation Product Surveillance, Postmarketing Arzneimittelsicherheit |
work_keys_str_mv | AT gadshaynec drugsafetyevaluation |